Previous close | 53.50 |
Open | 53.50 |
Bid | 59.30 |
Ask | 62.90 |
Strike | 70.00 |
Expiry date | 2024-05-17 |
Day's range | 53.50 - 53.50 |
Contract range | N/A |
Volume | |
Open interest | 7.19k |
Although the revenue and EPS for Sarepta Therapeutics (SRPT) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of 763.64% and 10.91%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
CAMBRIDGE, Mass., May 01, 2024--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the first quarter 2024.